Chandra Bhagat Pharma share news and announcements
BSE: 542934Pharmaceuticals & BiotechnologySmall Cap
Last close ₹39.00down ₹1.00 (2.50%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹40.00.
52-week range of traded prices to 23 Oct 2026
₹29.70Low, 6 May 2026₹52.99High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29 Cr3,869th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 25 May 2026
- 10.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 May 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 25 May 2026
- 9.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 0.50
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,000
Chandra Bhagat Pharma board meetings
46 filed, newest first.
Aug 2026
5 Aug · Board meeting
Jul 2026
30 Jul · Board meeting
Meeting on 5 Aug 2026: increase in authorised capital and preferential issue of shares
May 2026
19 May · Board meeting
Meeting on 25 May 2026: audited results
Nov 2025
7 Nov · Board meeting
Meeting on 13 Nov 2025: half yearly results
Sep 2025
6 Sep · Board meeting
May 2025
26 May · Board meeting
Meeting on 29 May 2025: audited results
Nov 2024
13 Nov · Board meeting
7 Nov · Board meeting
Meeting on 13 Nov 2024: half yearly results
Sep 2024
May 2024
30 May · Board meeting
23 May · Board meeting
Meeting on 30 May 2024: audited results
Nov 2023
2 Nov · Board meeting
Meeting on 9 Nov 2023: half yearly results
Sep 2023
5 Sep · Board meeting
May 2023
15 May · Board meeting
Meeting on 22 May 2023: audited results
Nov 2022
7 Nov · Board meeting
Meeting on 14 Nov 2022: half yearly results
Sep 2022
6 Sep · Board meeting
May 2022
17 May · Board meeting
Meeting on 26 May 2022: audited results
Nov 2021
13 Nov · Board meeting
8 Nov · Board meeting
Meeting on 13 Nov 2021: half yearly results
Oct 2021
20 Oct · Board meeting
Meeting on 20 Oct 202120 Oct · Board meeting
Jun 2021
22 Jun · Board meeting
Meeting on 29 Jun 2021: audited results
Nov 2020
5 Nov · Board meeting
Meeting on 14 Nov 2020: half yearly results
Jul 2020
30 Jul · Board meeting
Jun 2020
22 Jun · Board meeting
Meeting on 30 Jul 2020: audited results